Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver

    Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver

    FromBusiness Of Biotech

    Start listeningView podcast show

    Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver

    FromBusiness Of Biotech

    ratings:
    Length:
    36 minutes
    Released:
    Aug 10, 2020
    Format:
    Podcast episode

    Description

    Arrowhead Pharma CEO Christopher Anzalone, Ph.D. gives us the inside story on the stake his company claimed on the now re-burgeoning RNAi space, the indications his company is targeting beyond liver disease, and how it's addressing the development and process challenges that must be overcome to further progress RNAi beyond the liver.
    Released:
    Aug 10, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.